![]() |
市場調查報告書
商品編碼
1862367
重離子治療技術:全球市場佔有率和排名、總收入和需求預測(2025-2031 年)Heavy Ion Therapy Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2024 年全球重離子放射治療技術市場規模估計為 6.32 億美元,預計到 2031 年將擴大到 23.58 億美元,2025 年至 2031 年的複合年成長率為 19.6%。
重離子放射療法(HIR)是一種先進的癌症治療方法,它利用了重粒子獨特的物理和生物學特性。 HIR 將碳離子和其他重離子加速到接近光速的速度。這些高能量離子被瞄準腫瘤,將聚焦的輻射劑量直接送到癌細胞。與傳統的 X 光療法沿著人體整個路徑釋放能量不同,重離子放射療法具有獨特的能量釋放模式。輻射劑量隨深度增加,並在一個特定點達到最大值,該點稱為布拉格峰。布拉格峰可以被精確地定位在腫瘤內。這使得輻射能夠高度靶向地輸送,並最大限度地減少對周圍正常組織的損傷。本報告重點介紹重離子放射療法市場所需的設備。
傳統的重離子放射治療系統僅使用碳離子,而多離子放射治療則結合了針對特定惡性腫瘤最佳化的多種離子束,從而能夠以更少的副作用殺死更多癌細胞。 2022年,韓國量子科學技術振興機構(QST)和重離子科學研究所(SHI)成功研發出使用氖離子、氧離子和氦離子的多離子源,使多離子放射治療的實現更進一步。該系統已安裝在位於千葉的QST重離子醫學加速器(HIMAC)上,用於進一步研究。利用該系統,比碳重的氧離子照射到腫瘤中心,而比碳輕的氦離子則照射到靠近正常組織的區域。研究人員還分析了劑量分佈和生物效應分佈。與碳離子單藥治療的比較證實,不同離子束的合併治療更為有效。肉瘤的手術治療常會導致神經損傷(神經病變),具體情況取決於手術部位。重離子放射治療即使在治療難治性患者方面也取得了良好的效果。此外,治療體積較大的腫瘤時,復發是常見問題。首例採用多離子療法的病例於2023年11月至12月進行,對同一患者共進行了16次治療。這是首次在同一天進行碳離子和氧離子療法,兩種療法之間的切換也進行得非常順利。患者在治療後第二天出院,並在兩個月後的後續觀察中未觀察到早期副作用。
本報告旨在按地區/國家、類型和應用對全球重離子治療技術市場進行全面分析,重點關注總收入、市場佔有率和主要企業的排名。
本報告以收益為準,以2024年為基準年,對重離子治療技術的市場規模、估算和預測進行了闡述,並涵蓋了2020年至2031年的歷史數據和預測數據。定量和定性分析旨在幫助讀者制定業務/成長策略、評估市場競爭、分析公司在當前市場中的地位,並就重離子治療技術做出明智的商業決策。
市場區隔
公司
按類型分類的細分市場
應用領域
按地區
The global market for Heavy Ion Therapy Technology was estimated to be worth US$ 632 million in 2024 and is forecast to a readjusted size of US$ 2358 million by 2031 with a CAGR of 19.6% during the forecast period 2025-2031.
Heavy Ion Therapy Technology, or Heavy ion radiotherapy (HIR) is a sophisticated form of cancer treatment that employs accelerated heavy ions, most commonly carbon, to precisely target and destroy tumors. This method distinguishes itself from traditional radiotherapy by leveraging the unique physical and biological properties of these heavy ions. In HIR, carbon or other heavy ions are accelerated to a substantial fraction of the speed of light. These high-energy ions are then directed towards the tumor, delivering a concentrated dose of radiation directly to the cancerous cells. Unlike conventional X-ray therapy, which deposits energy along its entire path through the body, heavy ion therapy exhibits a distinct energy deposition pattern. The radiation dose increases with depth, reaching a maximum at a specific point known as the Bragg peak, which can be precisely positioned within the tumor. This allows for a highly targeted delivery of radiation, minimizing damage to surrounding healthy tissues. This report focuses on the devices for heavy ion therapy technology market.
In conventional heavy-particle radiotherapy equipment, only carbon ions are used. In multi-ion therapy, on the other hand, various kinds of ion beams-optimal for the specific malignancy-are combined to kill more cancer cells with fewer side effects. In 2022, QST and SHI succeeded in creating a multi-ion source, using neon, oxygen, and helium ions among others, making multi-ion radiotherapy possible. The system was installed at QST's Heavy Ion Medical Accelerator in Chiba (HIMAC) for further research. With the new system, oxygen, heavier than carbon, was irradiated to the center of a tumor, and helium, lighter than carbon, was irradiated to an area nearer to normal tissue. Dose distribution and distribution of biological effects were also analyzed. Through a comparison with cases where only carbon ions were irradiated, it was confirmed that using different ion beams was more effective. In surgical treatments for sarcoma, depending on the site of the operation, patients often experience nerve injuries (neuropathy). Satisfactory results have been obtained using heavy ions, even for those patients for whom surgery would not have been possible. Moreover, in treatments of very large tumors, recurrence has been a frequent problem. The first case using multi-ion therapy occurred in November and December 2023, involving irradiation applied on the same patient 16 times. For the first time, carbon and oxygen irradiations were done on the same day, and switching between them was conducted smoothly. The patient was discharged the day after the treatments ended, and no early side effects were seen two months later.
This report aims to provide a comprehensive presentation of the global market for Heavy Ion Therapy Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Heavy Ion Therapy Technology by region & country, by Type, and by Application.
The Heavy Ion Therapy Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heavy Ion Therapy Technology.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Heavy Ion Therapy Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Heavy Ion Therapy Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Heavy Ion Therapy Technology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.